Reverse signaling via PD-L1 supports malignant cell growth and survival in classical Hodgkin lymphoma

Treatment with programmed death-1 (PD-1) blocking antibodies results in high overall response rates in refractory and relapsed classical Hodgkin lymphoma (cHL) patients, indicating that PD-1/PD-1 ligand interactions are integral to progression of this disease. Given the genetically driven increased...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Blood Cancer J
Hlavní autoři: Jalali, Shahrzad, Price-Troska, Tammy, Bothun, Cole, Villasboas, Jose, Kim, Hyo-Jin, Yang, Zhi-Zhang, Novak, Anne J., Dong, Haidong, Ansell, Stephen M.
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group UK 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6381098/
https://ncbi.nlm.nih.gov/pubmed/30783096
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-019-0185-9
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky